Advertisement

European Journal of Clinical Pharmacology

, Volume 31, Issue 6, pp 719–722 | Cite as

Lidocaine protein binding in preeclampsia

  • M. B. Bottorff
  • J. A. Pieper
  • B. A. Boucher
  • T. J. Hoon
  • J. Ramanathan
  • B. M. Sibai
Short Communications
  • 16 Downloads

Summary

The effect of preeclampsia on the binding of lidocaine to serum proteins was studied in 25 term parturients with severe preeclampsia and in 21 normal parturients serving as controls. There were no statistically significant differences in mean lidocaine free fraction, binding ratio, or serum AAG levels in the control vs preeclamptic patients, respectively. Binding ratio was strongly correlated with AAG concentration for the control (r=0.91) and preeclamptic (r=0.85) patients. A statistically significant difference was observed in the slopes of the lines relating binding ratio to AAG. Preeclampsia had little affect on serum AAG concentrations and lidocaine binding ratio. Preeclampsia may alter the interaction of lidocaine with binding sites on AAG without a significant change in lidocaine free fraction.

Key words

lidocaine preeclampsia protein binding alpha1-acid glycoprotein parturients 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Albright GA (1979) Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 51: 285–287Google Scholar
  2. 2.
    Reisner LS, Hockman BN, Plumer MH (1980) Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine injection. Anesth Analg 59: 452–454Google Scholar
  3. 3.
    Abboud TK, Kim KC, Noueihed R, et al (1983) Epidural bupivacaine, chloroprocaine, or lidocaine for cesarean section. Maternal and neonatal effects. Anesth Analg 62: 914–919Google Scholar
  4. 4.
    Abboud TK, David S, Nagappala S, et al (1984) Maternal, fetal and neonatal effects of lidocaine with and without epinephrine for epidural anesthesia in obstetrics. Anesth Analg 63: 973–979Google Scholar
  5. 5.
    Good W (1975) Maternal serum sialomucins during pregnancy and postpartum in patients with preeclampsia. Br J Obstet Gynaecol 82: 907–916Google Scholar
  6. 6.
    Studd JWW, Shaw RW, Bailey DE (1972) Maternal and fetal serum protein concentration in normal pregnancy and pregnancy complicated by proteinuric preeclampsia. Am J Obstet Gynecol 114: 582–588Google Scholar
  7. 7.
    McNamara PJ, Slaughter RL, Pieper JA, et al (1981) Factors influencing the serum protein binding of lidocaine in humans. Anesth Analg 60: 395–400Google Scholar
  8. 8.
    Edwards DJ, Lalka D, Cerra F, et al (1982) Alpha1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther 31: 62–67Google Scholar
  9. 9.
    Pieper JA, Wyman MG, Goldreyer BN, et al (1980) Lidocaine toxicity: Effects of total vs free lidocaine concentrations. Circulation 62: 181Google Scholar
  10. 10.
    Huang J (1983) Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis. J Pharm Sci 72: 1368–1369 (letter)Google Scholar
  11. 11.
    Zar JH (1984) Biostatistical analysis. Prentice-Hall, Englewood Cliffs, New Jersey, USA, pp 292–305Google Scholar
  12. 12.
    Wood M, Wood AJJ (1981) Changes in plasma drug binding and alpha1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther 29: 522–526Google Scholar
  13. 13.
    Song CS, Merkatz IR, Rifkind AB, et al (1970) The influence of pregnancy and oral contraceptive steroids on the concentration of plasma proteins. Am J Obstet Gynecol 108: 227–231Google Scholar
  14. 14.
    Morgan DJ, Koay BB, Paull JD (1982) Plasma protein binding of etidocaine during pregnancy and labour. Eur J Clin Pharmacol 22: 451–457Google Scholar
  15. 15.
    Ramanathan J, Bottorff MB, Jeter JN, et al (1986) The pharmacokinetics and maternal and neonatal effects of epidural lidocaine in preeclampsia. Anesth Analg 65: 120–126Google Scholar
  16. 16.
    Nilsen OG, Leren P, Aakesson I, Jacobsen S (1978) Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein. Biochem Pharmacol 27: 871–876Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • M. B. Bottorff
    • 1
  • J. A. Pieper
    • 1
  • B. A. Boucher
    • 1
  • T. J. Hoon
    • 1
  • J. Ramanathan
    • 2
  • B. M. Sibai
    • 3
  1. 1.Department of Clinical PharmacyUniversity of TennesseeMemphisUSA
  2. 2.Department of AnesthesiologyUniversity of TennesseeMemphisUSA
  3. 3.Department of Obstetrics and GynecologyUniversity of TennesseeMemphisUSA

Personalised recommendations